AU2001288094A1 - Method of regulating osteoclast formation - Google Patents

Method of regulating osteoclast formation

Info

Publication number
AU2001288094A1
AU2001288094A1 AU2001288094A AU8809401A AU2001288094A1 AU 2001288094 A1 AU2001288094 A1 AU 2001288094A1 AU 2001288094 A AU2001288094 A AU 2001288094A AU 8809401 A AU8809401 A AU 8809401A AU 2001288094 A1 AU2001288094 A1 AU 2001288094A1
Authority
AU
Australia
Prior art keywords
osteoclast formation
regulating osteoclast
regulating
formation
osteoclast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288094A
Inventor
Kozo Nakamura
Hiroshi Takayanagi
Tadatsugu Taniguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Todai TLO Ltd
Original Assignee
Ct For Advanced Science & Tech
Center for Advanced Science and Technology Incubation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Advanced Science & Tech, Center for Advanced Science and Technology Incubation Ltd filed Critical Ct For Advanced Science & Tech
Publication of AU2001288094A1 publication Critical patent/AU2001288094A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001288094A 2000-09-21 2001-09-21 Method of regulating osteoclast formation Abandoned AU2001288094A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000286353 2000-09-21
JP2000-286353 2000-09-21
PCT/JP2001/008244 WO2002024228A1 (en) 2000-09-21 2001-09-21 Method of regulating osteoclast formation

Publications (1)

Publication Number Publication Date
AU2001288094A1 true AU2001288094A1 (en) 2002-04-02

Family

ID=18770289

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288094A Abandoned AU2001288094A1 (en) 2000-09-21 2001-09-21 Method of regulating osteoclast formation

Country Status (3)

Country Link
JP (1) JPWO2002024228A1 (en)
AU (1) AU2001288094A1 (en)
WO (1) WO2002024228A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067974A1 (en) * 2004-01-19 2005-07-28 Orient Cancer Therapy Co., Ltd. Drug for regulating cancer metastasis to bone
JP4934812B2 (en) * 2004-12-21 2012-05-23 国立大学法人 奈良先端科学技術大学院大学 NFAT2 expression suppression method
EP2623978A1 (en) 2012-02-03 2013-08-07 Charité - Universitätsmedizin Berlin CD8+ T-cell subsets as markers for prediction of delayed fracture healing
CN105759053B (en) * 2016-03-18 2018-06-29 中国人民解放军第四军医大学 A kind of kit for osteoporosis early prediction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519361A1 (en) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (GAMMA) -IFN AS AN ACTIVE SUBSTANCE FOR INHIBITING (PREVENTING) DEGREASING PROCESSES IN THE BONE
JPH07215893A (en) * 1994-02-04 1995-08-15 Hiroyo Morii Bone quantity increasing agent
JP4066460B2 (en) * 1995-07-25 2008-03-26 東レ株式会社 Bone disease treatment
CZ2001789A3 (en) * 1998-09-15 2001-08-15 Pharmexa A/S Method for in vivo inhibition of osteoprotegerin ligand activity

Also Published As

Publication number Publication date
WO2002024228A1 (en) 2002-03-28
JPWO2002024228A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AU2002222568A1 (en) Method of refining petroleum
AU2002332638A1 (en) Method for the preparation of crystalline tetrahydrobenzothiepines
AU2001288831A1 (en) Method of compensating flare-induced cd changes
AU2001270307A1 (en) Method of making teprenone
AU2002302243A1 (en) Method for determination of co-occurences of attributes
AU2001291019A1 (en) Method of modulating neovascularization
AU2001278739A1 (en) Method of modifying microorganism-origin transglutaminase
AU2003248990A1 (en) Method of controlling scale formation
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU2002223548A1 (en) Improved method for the biosynthesis of vitamin e
AU2001288092A1 (en) Method of crystallization
AU7964600A (en) Production method of radiators
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
AU2001294258A1 (en) Method of purifying plavastatin
AU2001213451A1 (en) Method for preparation of polycarbonates
AU4124101A (en) Method of making silver-contained candle
AU2001288095A1 (en) Method of regulating osteoclast formation
AU2001288094A1 (en) Method of regulating osteoclast formation
AU2002211285A1 (en) Method of making nanoshells
EP1243564A3 (en) Process for preventing formation of scale
AU5861700A (en) Method of threading
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU6907201A (en) Method for the production of caprolactam